These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 25364261)
21. A phase I/II study of hepatic artery infusion with wtp53-CMV-Ad in metastatic malignant liver tumours. Habib NA; Hodgson HJ; Lemoine N; Pignatelli M Hum Gene Ther; 1999 Aug; 10(12):2019-34. PubMed ID: 10466636 [TBL] [Abstract][Full Text] [Related]
22. A novel apoptotic mechanism of genetically engineered adenovirus-mediated tumour-specific p53 overexpression through E1A-dependent p21 and MDM2 suppression. Yamasaki Y; Tazawa H; Hashimoto Y; Kojima T; Kuroda S; Yano S; Yoshida R; Uno F; Mizuguchi H; Ohtsuru A; Urata Y; Kagawa S; Fujiwara T Eur J Cancer; 2012 Sep; 48(14):2282-91. PubMed ID: 22244827 [TBL] [Abstract][Full Text] [Related]
23. Tumor suppression and therapy sensitization of localized and metastatic breast cancer by adenovirus p53. Lebedeva S; Bagdasarova S; Tyler T; Mu X; Wilson DR; Gjerset RA Hum Gene Ther; 2001 May; 12(7):763-72. PubMed ID: 11339893 [TBL] [Abstract][Full Text] [Related]
25. Adenovirus-mediated transfer of p53 and p16(INK4a) results in pancreatic cancer regression in vitro and in vivo. Ghaneh P; Greenhalf W; Humphreys M; Wilson D; Zumstein L; Lemoine NR; Neoptolemos JP Gene Ther; 2001 Feb; 8(3):199-208. PubMed ID: 11313791 [TBL] [Abstract][Full Text] [Related]
26. Induction of apoptosis in human lung cancer cells following treatment with amifostine and an adenoviral vector containing wild-type p53. Pataer A; Fanale MA; Roth JA; Swisher SG; Hunt KK Cancer Gene Ther; 2006 Aug; 13(8):806-14. PubMed ID: 16628227 [TBL] [Abstract][Full Text] [Related]
27. Restoration of p53 function in anaplastic Wilms' tumor. Delatte SJ; Hazen-Martin DJ; Re GG; Kelly JR; Sutphin A; Tagge EP J Pediatr Surg; 2001 Jan; 36(1):43-50. PubMed ID: 11150436 [TBL] [Abstract][Full Text] [Related]
28. p53 Plays a Key Role in the Apoptosis of Human Ovarian Cancer Cells Induced by Adenovirus-Mediated CRM197. Dai L; Pan Q; Peng Y; Huang S; Liu J; Chen T; Wang X; Chen D; Wang J; Zhu Y; Wang H; Liu Y; Ou Y; Yu X; Cao K Hum Gene Ther; 2018 Aug; 29(8):916-926. PubMed ID: 29620944 [TBL] [Abstract][Full Text] [Related]
29. AdDelta24 and the p53-expressing variant AdDelta24-p53 achieve potent anti-tumor activity in glioma when combined with radiotherapy. Idema S; Lamfers ML; van Beusechem VW; Noske DP; Heukelom S; Moeniralm S; Gerritsen WR; Vandertop WP; Dirven CM J Gene Med; 2007 Dec; 9(12):1046-56. PubMed ID: 17966130 [TBL] [Abstract][Full Text] [Related]
31. Oncolytic activity of the E1B-55 kDa-deleted adenovirus ONYX-015 is independent of cellular p53 status in human malignant glioma xenografts. Geoerger B; Grill J; Opolon P; Morizet J; Aubert G; Terrier-Lacombe MJ; Bressac De-Paillerets B; Barrois M; Feunteun J; Kirn DH; Vassal G Cancer Res; 2002 Feb; 62(3):764-72. PubMed ID: 11830531 [TBL] [Abstract][Full Text] [Related]
32. A system for small-molecule control of conditionally replication-competent adenoviral vectors. Chong H; Ruchatz A; Clackson T; Rivera VM; Vile RG Mol Ther; 2002 Feb; 5(2):195-203. PubMed ID: 11829527 [TBL] [Abstract][Full Text] [Related]
33. Transduction of adenovirus-mediated wild-type p53 after radiotherapy in human cervical cancer cells. Huh JJ; Wolf JK; Fightmaster DL; Lotan R; Follen M Gynecol Oncol; 2003 May; 89(2):243-50. PubMed ID: 12713987 [TBL] [Abstract][Full Text] [Related]
34. Use of replication-conditional adenovirus as a helper system to enhance delivery of P450 prodrug-activation genes for cancer therapy. Jounaidi Y; Waxman DJ Cancer Res; 2004 Jan; 64(1):292-303. PubMed ID: 14729637 [TBL] [Abstract][Full Text] [Related]